Qizheng Tibetan Medicine Makes Its Debut in New York’s Times Square

Release time:

2017-06-29 14:35

　　Recently, the brand advertisement of Qizheng Tibetan Medicine (002287) made its debut on the Nasdaq advertising billboard in New York’s Times Square, making it the first company to showcase a traditional Chinese medicine brand there.

　　As a leading domestic enterprise in Tibetan medicine, Qizheng Tibetan Medicine is committed to becoming the “modern inheritor of millennia-old Tibetan medicinal traditions.” In recent years, the company has also been actively pursuing internationalization; its products first entered overseas markets as early as 2003. In 2013, Qizheng Tibetan Medicine further collaborated with Professor David Christiani, an internationally renowned expert in occupational disease research and a professor at Harvard University, to establish the “Harvard University Professor David Christiani–Qizheng Tibetan Medicine Research Laboratory,” which focuses on the role and expansion of Tibetan medicine in addressing major diseases from a global perspective.

　　New York’s Times Square in the United States is renowned as “the Crossroads of the World,” attracting tourists from all over the globe every day. It serves as a premier showcase for the world’s most prominent brands and has become one of the best windows for Chinese enterprises to go global and capture worldwide attention. In recent years, the Chinese government has emphasized accelerating the internationalization of traditional Chinese medicine (TCM), providing fresh momentum for TCM’s global outreach. As a result, an increasing number of TCM companies have stepped up their efforts to promote TCM culture overseas, enabling the world to gain a deeper understanding of and embrace TCM—a uniquely Chinese medicinal tradition—and fostering the internationalization of the TCM industry, thus allowing the world to share in the treasures and wisdom of this remarkable indigenous medical system. Qizheng Tibetan Medicine’s appearance on the big screen at Times Square this time will enable the world to appreciate the distinctive culture of Tibetan medicine and further accelerate the international journey of Chinese ethnic medicine enterprises.

　　It is reported that currently, 4 billion people worldwide use traditional Chinese medicine products, and the global TCM market has reached an annual turnover of nearly 500 billion yuan. Chinese medicinal herbs are now exported to 168 countries and regions, with Asia being the primary export market for TCM, followed by the United States as the second-largest market. Aside from China, 64 countries across Europe, Asia, Africa, the Americas, and Oceania have successively established research and management institutions dedicated to traditional Chinese medicine and ethnic medicine, totaling over 2,000 such organizations. Among these, Japan, the United States, and Germany have the largest numbers of researchers specializing in TCM. Currently, about 5% of patients in the United States take natural medicines, including Chinese herbal remedies. Across the U.S., there are approximately 12,000 pharmacies—ranging from traditional Chinese medicine shops to integrated Chinese-Western medicine stores or health product stores selling Chinese herbs—whose annual sales exceed 2 billion U.S. dollars.

　　Reporting media: Securities Times

　　Report link: http://company.stcn.com/2017/0629/13451286.shtml

Ethnic medicine brand makes its debut at New York's Times Square.

Qizheng Tibetan Medicine Debuts in New York’s Times Square